芪苈强心胶囊治疗老年慢性收缩性心力衰竭的临床疗效观察

发布时间：2018-01-01 16:48

本文关键词：芪苈强心胶囊治疗老年慢性收缩性心力衰竭的临床疗效观察　出处：《中国医药指南》2017年11期 　论文类型：期刊论文

【摘要】：目的观察本地区芪苈强心胶囊治疗老年慢性收缩性心力衰竭患者的临床疗效。方法收集2013年1月至2015年12月在我院住院的老年慢性收缩性心力衰竭患者310例,随机分为观察组186例和对照组124例。对照组患者使用常规药物进行治疗,观察组在对照组基础上加用芪苈强心胶囊进行治疗。于入组及治疗后3个月检测血清N末端脑钠肽前体(NT-pro BNP)、临床疗效6 min步行试验、左室射血分数(LVEF)、治疗有效率的变化。结果两组患者在治疗后各观察指标均较治疗前有明显差异(P0.05)。观察组总有效率65.6%,明显高于对照组的37.4%,差异有统计学意义(P0.05)。观察组无明显不良反应。结论芪苈强心胶囊能有效改善老年收缩性心力衰竭患者的临床症状和促进心功能恢复,减少再住院率,无用药不良反应发生。
[Abstract]:Objective to observe the clinical effect of Qiliqiangxin capsule on elderly patients with chronic systolic heart failure (CHF). 310 patients were exhausted. The patients were randomly divided into observation group (n = 186) and control group (n = 124). The observation group was treated with Liqiqiangxin capsule on the basis of the control group. The serum N-terminal brain natriuretic peptide precursor (NT-pro BNPP) was detected in the experimental group and 3 months after treatment. The clinical efficacy was 6 min walking test, left ventricular ejection fraction (LVEF). Results there was significant difference between the two groups after treatment. The total effective rate of the observation group was 65.6, which was significantly higher than that of the control group (37.4%). There was no significant adverse reaction in the observation group. Conclusion Qiliqiangxin capsule can effectively improve the clinical symptoms and promote the recovery of cardiac function in elderly patients with systolic heart failure. The rate of re-hospitalization was reduced and no adverse drug reaction occurred.
【作者单位】：西安航天总医院急诊科;
【分类号】：R259
【正文快照】： 随着我国老龄化社会的来临,慢性心力衰竭(chronic heart failure,病性心肌病,常合并有脑血管疾病,导致记忆力下降,机体抵抗力明CHF)的发病率越来越高,严重危害人类健康。老年人心力衰竭特点显下降,合并多种慢性疾病共存,临床症状复杂多样,但往往心力衰为多继发于冠心病、心肌

【相似文献】